A Pillsbury team led by Silicon Valley Corporate partner Stan Pierson represented BioDiscovery, Inc., a leading software company with best-in-class solutions for analysis, interpretation and reporting of genomics data, in a definitive agreement to be acquired by Bionano Genomics, Inc.

The transaction is expected to accelerate and broaden Bionano’s market leadership in digital cytogenetics and comprehensive genome analysis.

BioDiscovery specializes in delivering superior data analysis, visualization, interpretation and reporting solutions with an emphasis on structural variation. BioDiscovery has been delivering platform-agnostic data interpretation solutions tailored for cytogenomics and molecular pathology labs in genetic disease and cancer research markets globally for over 20 years.

Bionano’s transaction consideration will be up to $100 million, consisting of a combination of cash and equity.

In addition to Stan Pierson, the Pillsbury team included Corporate senior associate Drew Simon-Rooke and associates Jasmine Alves, Juan Pablo Cordon and Andrew Clark, Executive Compensation & Benefits counsel Colleen Lamarre, International Trade counsel Matt Rabinowitz, senior counsel George Willman and senior associate Clinton Jang in the area of intellectual property, and Tax partner C. Brian Wainwright and senior counsel Laura Watts.